Showing results (181-190 of 227) with videos related to
Sort By:
Pageof 23
The Lancet. Oncology|March 1, 2020
Camrelizumab in patients with previously treated advanced hepatocellular carcinoma: a multicentre, open-label, parallel-group, randomised, phase 2 trialShukui Qin, Zhenggang Ren, Zhiqiang Meng, et al.Molecular Cancer|March 25, 2023
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironmentRuiwen Ruan, Li Li, Xuan Li, et al.Cell Death & Disease|April 13, 2025
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancerChunye Huang, Qinru Zeng, Jingyi Chen, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
A multicentre randomised trial comparing weekly paclitaxel + S-1 with weekly paclitaxel + 5-fluorouracil for patients with advanced gastric cancerDingzhi Huang, Yi Ba, Jianping Xiong, et al.The Lancet. Oncology|September 15, 2018
Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trialsWenfeng Fang, Yunpeng Yang, Yuxiang Ma, et al.Cancer Immunology, Immunotherapy : CII|February 21, 2020
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapyMeng Zhang, Yanmei Shi, Yujuan Zhang, et al.Journal of Hematology & Oncology|May 13, 2020
Reactive cutaneous capillary endothelial proliferation in advanced hepatocellular carcinoma patients treated with camrelizumab: data derived from a multicenter phase 2 trialFeng Wang, Shukui Qin, Xinchen Sun, et al.Journal of the American Society of Nephrology : JASN|August 4, 2012
Aquaporin 2 promotes cell migration and epithelial morphogenesisYing Chen, William Rice, Zhizhan Gu, et al.Journal of Hematology & Oncology|January 11, 2018
Correction to: Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort studyXinyang Liu, Shukui Qin, Zhichao Wang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 7, 2013
Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trialJin Li, Shukui Qin, Jianming Xu, et al.Pageof 23